Cargando…
Quantitative Proteomic Profiling Identifies SOX8 as Novel Regulator of Drug Resistance in Gestational Trophoblastic Neoplasia
The development of drug resistance remains one of the major challenges to current chemotherapeutic regimens in gestational trophoblastic neoplasia (GTN). Further understanding on the mechanisms of drug resistance would help to develop more effective therapy to treat GTN. Herein, tandem mass tag-base...
Autores principales: | Jun, Fu, Peng, Zheng, Zhang, Yi, Shi, Dazun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198745/ https://www.ncbi.nlm.nih.gov/pubmed/32411596 http://dx.doi.org/10.3389/fonc.2020.00557 |
Ejemplares similares
-
DPP4 Regulates DHCR24-Mediated Cholesterol Biosynthesis to Promote Methotrexate Resistance in Gestational Trophoblastic Neoplastic Cells
por: Yuan, Weijie, et al.
Publicado: (2021) -
Monotherapy for low-risk gestational trophoblastic neoplasia with score 5-6
por: Kemin, Li, et al.
Publicado: (2022) -
Gestational Trophoblastic Neoplasia With Urinary System Metastasis: A Single Center Experience
por: Cheng, Hongyan, et al.
Publicado: (2020) -
Gestational trophoblastic neoplasia in the 1990s.
por: Goldstein, D. P.
Publicado: (1991) -
Expression of the immune targets in tumor-infiltrating immunocytes of gestational trophoblastic neoplasia
por: Cheng, Hongyan, et al.
Publicado: (2023)